<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00161980</url>
  </required_header>
  <id_info>
    <org_study_id>550002</org_study_id>
    <nct_id>NCT00161980</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites</brief_title>
  <official_title>A Randomized and Controlled Clinical Study to Evaluate the Efficacy and Safety of Fibrin Sealant VH S/D (FS VH S/D) in Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baxter Healthcare Corporation</source>
  <brief_summary>
    <textblock>
      This study will monitor the safety of FS VH S/D and will evaluate whether FS VH S/D is
      superior to conventional surgical procedures in the reduction of lymphatic leakage by sealing
      the axillary lymphatics in subjects undergoing lumpectomy and level I and II axillary lymph
      node dissection with two separate incisions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2001</start_date>
  <completion_date>December 2002</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <condition>Breast Cancer</condition>
  <condition>Lumpectomy</condition>
  <condition>Mastectomy Plus Axillary Lymph Node Dissection</condition>
  <condition>Lymphatic Leakage</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fibrin Sealant VH S/D</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical intervention alone without Fibrin Sealant VH S/D application</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent has been obtained from the subject prior to FS VH S/D
             administration

          -  Female subjects &gt;= 19 years of age

          -  Subjects with breast cancer scheduled to undergo lumpectomy of the breast and level I
             and II axillary lymphadenectomy with two separate incisions

        Exclusion Criteria:

          -  Subjects with known hypersensitivity to aprotinin or other components of the product

          -  Subjects with immunodeficiency

          -  Subjects with increased red cell production (e.g., in hemolytic anemia)

          -  Subjects with coagulation disorders shown by exceeding the normal range of any of
             following: prothrombin time (PT), Quick, activated partial thromboplastin time (aPTT),
             fibrinogen level, or thrombocytes.

          -  Subjects having previously had axillary surgery

          -  Subjects having undergone irradiation therapy to the axillary tissue

          -  Subjects having ever received chemotherapy before the surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Berger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>General Hospital / University Hospital Vienna, Austria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Diethelm Wallwiener, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tübingen, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Landeskrankenhaus St. Pölten</name>
      <address>
        <city>St. Pölten</city>
        <state>Niederösterreich</state>
        <zip>3100</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus der Stadt Wien, University Clinic for Gynecology</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Régional de Lutte Contre le Cancer, Centre Eugène Marquis</name>
      <address>
        <city>Rennes</city>
        <zip>35062</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ludwig-Maximilians-Universität</name>
      <address>
        <city>Munich</city>
        <zip>80337</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen, Frauenklinik</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum - Frauenklinik</name>
      <address>
        <city>Würzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>S. Luigi - S. Curro, Presidi Ospedalieri Unificati</name>
      <address>
        <city>Catania</city>
        <zip>95100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Nationale per la Ricerca sul Cancro</name>
      <address>
        <city>Genova</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2005</study_first_posted>
  <last_update_submitted>October 20, 2006</last_update_submitted>
  <last_update_submitted_qc>October 20, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 23, 2006</last_update_posted>
  <keyword>Axillary wound</keyword>
  <keyword>Seroma</keyword>
  <keyword>Fistulae</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrin Tissue Adhesive</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

